Correspondence 0001493152-22-034561 from Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc.
Date: Dec. 6, 2022 · CIK: 0001716947 · Accession: 0001493152-22-034561
AI Filing Summary & Sentiment
File numbers found in text: 333-268038
Show Raw Text
CORRESP
1
filename1.htm
Lake
Street Capital Markets, LLC
920
Second Avenue South, Suite 700
Minneapolis,
Minnesota 55402
December
6, 2022
U.S.
Securities and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Alan Campbell
Re:
Ensysce
Biosciences, Inc. (the “Company”)
Registration Statement on Form S-1/A (File No. 333-268038)
Ladies
and Gentlemen:
In
connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the
“Act”), Lake Street Capital Markets, LLC, as underwriter, hereby joins in the request of the Company that the effective date
of such registration statement be accelerated to 5:00 p.m. (New York time) on December 6, 2022, or as soon thereafter as practicable.
In
making this request the undersigned acknowledges that the underwriter is aware of its obligations under the Act as they relate to the
public offering of securities pursuant to the registration statement.
[Signature
Page Follows]
Very
truly yours,
LAKE
STREET CAPITAL MARKETS, LLC
As Underwriter
By:
/s/
Michael Townley
Name:
Michael
Townley
Title:
Head
of Investment Banking